ZEPP
Zepp Health Corporation
3.80$
-3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 15 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.8 | -6.1 | -98 | -98 | 48 | -98 | -13 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | 1,665 | – | – | – | 623 | – | – | – | 671 | – | – | – | – | – | – | – | – | – | – | -180 | -26 | – | – | |
| 0.3 | 1.3 | 1.2 | 1.2 | – | 1.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | 169 | – | – | – | -7.8 | – | – | – | -8.4 | – | – | 0.1 | 0.6 | – | – | – | 4.1 | 5.1 | – | -4.0 | -0.6 | – | – | |
| – | 14 | 2.1 | 2.2 | 2.9 | 14 | 12 | 2.4 | 3.0 | – | 2.9 | 3.3 | 0.9 | – | 0.9 | – | – | – | 1.7 | 6.2 | 2.5 | – | 2.1 | 1.9 | – | – | -97 | – | – | – | 16 | 12 | 4.5 | 6.9 | 6.9 | 3.5 | – | 17 | 6.4 | 4.9 | – | |
| 53 | 42 | 17 | 17 | 0.8 | 41 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30 | – | – | – | -189 | -27 | – | – | – | – | – | – | – | – | – | – | – | 1,230 | – | – | – | 1,200 | – | – | – | 1,292 | – | – | – | – | – | – | – | – | – | – | -110 | -16 | – | – | |
| 0.5 | 0.4 | 19 | 19 | 0.4 | 19 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 420 | 0.0 | 0.0 | 0.0 | 122 | 0.0 | 0.0 | 0.0 | 132 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.5 | 0.8 | 0.0 | 6.3 | |
| -4.9 | -1.1 | -33 | -33 | -0.8 | -39 | -4.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | -1,132 | – | – | – | 212 | – | – | – | 229 | – | – | – | – | – | – | – | – | – | – | 10 | 1.5 | – | – | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | – | – | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -8.7 | -1.2 | – | – | |
| 10 | 10 | -10 | -10 | – | 20 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 33 | 10 | -10 | -10 | 5.7 | -10 | -2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | 3,750 | – | – | – | 64 | – | – | – | 69 | – | – | – | – | – | – | – | – | – | – | 174 | 25 | – | – | |
| 213 | 22 | -22 | -142 | 77 | -142 | -59 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 18 | 0.8 | – | -28 | – | – | – | 47 | – | -7.1 | -1.8 | 5.7 | 0.7 | -12 | 0.9 | -60 | -25 | -6.5 | – | -50 | -61 | – | 790 | 113 | – | – | |
| – | -6.5 | – | – | – | -117 | -14 | – | – | – | – | – | – | – | – | – | – | – | 1,245 | – | – | – | 745 | – | – | – | 802 | – | – | – | – | – | – | – | – | – | – | -185 | -26 | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.